Murray Stewart, M.D., is Chief Medical Officer at GlaxoSmithKline, a position he has held since April 2014. Dr. Stewart joined GSK in 2000 as Associate Director for Clinical Research & Development in the UK and since then has held a variety of positions in GSK he worked in Biopharm, was Therapy Area Head for the Cardiovascular and Metabolic therapy area. Currently he is Chief Medical Officer for GSK and as such has global responsibility for patient well-being across the vaccines, pharmaceutical and consumer business units. He has had extensive clinical development experience and worldwide regulatory interactions. Before joining the pharmaceutical industry, Dr. Stewart worked as a diabetes consultant and senior lecturer and was Consultant Physician/Honorary Senior Lecturer and Head of Clinical Services at the Diabetes Centre, Newcastle upon Tyne in the UK. His research was in lipid metabolism in type-2 diabetes, and he completed his medical training at Southampton Medical School in the UK and is a Fellow of the Royal College of Physicians.
Murray Stewart, MD
Chief Medical Officer, GlaxoSmithKline